费城染色体阳性急性淋巴细胞白血病：我们仍需要异基因移植吗？正方观点。 - Suppr | 超能文献

Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".

作者信息

Bachanova Veronika

机构信息

Bone Marrow Transplantation Program, University of Minnesota, Minneapolis, MN.

出版信息

Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S10-S15. doi: 10.1016/j.clml.2017.03.296.

DOI:10.1016/j.clml.2017.03.296

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".费城染色体阳性急性淋巴细胞白血病：我们仍需要异基因移植吗？正方观点。

Clin Lymphoma Myeloma Leuk. 2017 Jul;17S:S10-S15. doi: 10.1016/j.clml.2017.03.296.

2

[Molecular response and prognostic factors of patients with Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia treated by imatinib with chemotherapy].[伊马替尼联合化疗治疗费城染色体/BCR-ABL阳性急性淋巴细胞白血病患者的分子反应及预后因素]

Zhonghua Xue Ye Xue Za Zhi. 2014 Feb;35(2):120-5. doi: 10.3760/cma.j.issn.0253-2727.2014.02.013.

3

Minimal residual disease-based long-term efficacy of reduced-intensity conditioning versus myeloablative conditioning for adult Philadelphia-positive acute lymphoblastic leukemia.基于微小残留病灶的成人费城阳性急性淋巴细胞白血病的低强度预处理与清髓性预处理的长期疗效比较。

Cancer. 2019 Mar 15;125(6):873-883. doi: 10.1002/cncr.31874. Epub 2018 Dec 6.

4

Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).费城染色体阳性急性淋巴细胞白血病（Ph+ ALL）的治疗管理。

Hematology Am Soc Hematol Educ Program. 2009:371-81. doi: 10.1182/asheducation-2009.1.371.

5

Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.达沙替尼诱导费城染色体阳性急性淋巴细胞白血病患儿第二次缓解后成功进行第二次异基因干细胞移植。

Pediatr Blood Cancer. 2009 Jul;52(7):891-2. doi: 10.1002/pbc.21938.

6

Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病造血干细胞移植后使用达沙替尼进行预防性和抢先性治疗。

Biol Blood Marrow Transplant. 2012 Apr;18(4):652-4. doi: 10.1016/j.bbmt.2011.12.587. Epub 2012 Jan 9.

7

[Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].[费城染色体阳性急性淋巴细胞白血病的当前治疗方法]

Rinsho Ketsueki. 2014 Oct;55(10):1972-80.

8

Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.额外细胞遗传学异常对接受异基因造血细胞移植的费城染色体阳性成人急性淋巴细胞白血病患者的影响。

Biol Blood Marrow Transplant. 2015 Jul;21(7):1326-9. doi: 10.1016/j.bbmt.2015.03.021. Epub 2015 Apr 1.

9

Impact of tyrosine kinase inhibitors on patient outcomes in Philadelphia chromosome-positive acute lymphoblastic leukaemia.酪氨酸激酶抑制剂对费城染色体阳性急性淋巴细胞白血病患者预后的影响。

Br J Haematol. 2009 Jun;145(5):581-97. doi: 10.1111/j.1365-2141.2009.07666.x. Epub 2009 Apr 15.

10

Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?酪氨酸激酶抑制剂用于移植后维持治疗能否改善高危费城染色体阳性白血病患者的预后？

Clin Lymphoma Myeloma Leuk. 2016 Aug;16(8):466-471.e1. doi: 10.1016/j.clml.2016.04.017. Epub 2016 May 5.

引用本文的文献

1

Hematopoietic stem cell transplantation from HLA-matched sibling donors in children with acute lymphoblastic leukemia: A report from the Children's Cancer Hospital Egypt.埃及儿童癌症医院报告：急性淋巴细胞白血病患儿接受来自人类白细胞抗原匹配同胞供者的造血干细胞移植情况

Front Oncol. 2022 Sep 27;12:983220. doi: 10.3389/fonc.2022.983220. eCollection 2022.